CJC-1295
A GHRH analog with a DAC modification that extends half-life, enabling once or twice-weekly dosing for sustained GH elevation.
Also known as: GRF (1-29), GHRH Analog
Available on Forge Amino
CJC-1295 / Ipamorelin Blend — independently lab tested, 99%+ purity, QR-linked COA.
Important: This content is for informational and research purposes only and is not intended for human or veterinary use. Consult your physician for health-related guidance and laboratory monitoring.
How It Works
Binds GHRH receptors on somatotroph cells, stimulating GH synthesis and pulsatile release. DAC (Drug Affinity Complex) enables albumin binding for 6-10 day half-life.
Key Benefits
- ✓2-10 fold GH elevation sustained 6+ days
- ✓1.5-3 fold IGF-I elevation
- ✓Enhanced muscle protein synthesis
- ✓Visceral fat reduction
- ✓Improved sleep quality
Dosing Protocols
Beginner / Intermediate
Dose
100 mcg
Frequency
Before bed subcutaneous
Cycle Length
8-12 weeks
Notes
Inject on empty stomach; fast 90-120 min before and 30-60 min after
Advanced
Dose
100-200 mcg
Frequency
Twice daily subcutaneous
Cycle Length
12-16 weeks
Notes
Stack with ipamorelin for synergistic GH pulse amplification
Side Effects & Safety
Common Side Effects
- Flushing or warmth sensation
- Water retention and mild edema
- Headache or dizziness
- Joint pain (from IGF-I elevation)
Contraindications
- Pregnancy and breastfeeding
- Active cancer or cancer history
- Acute critical illness
- Pre-diabetes (caution: insulin antagonism)
- Acromegaly or pituitary disease
Stacking & Synergies
These compounds have complementary mechanisms and may enhance results when used together.
Key Takeaway
Sustained GH elevation: CJC-1295 extends GHRH signaling for days with convenient weekly dosing.
Research Disclaimer: This content is for informational and research purposes only. It is not medical advice. These products are not approved by the FDA for human consumption. Consult a qualified healthcare provider before starting any new protocol. The information provided is based on preclinical research and anecdotal reports and has not been formally evaluated in randomized controlled trials.